File Download

There are no files associated with this item.

  Links for fulltext
     (May Require Subscription)
Supplementary

Article: Surface‐Engineered Extracellular Vesicles with CDH17 Nanobodies to Efficiently Deliver Imaging Probes and Chemo‐Photothermal Drugs for Gastric Cancer Theragnostic

TitleSurface‐Engineered Extracellular Vesicles with CDH17 Nanobodies to Efficiently Deliver Imaging Probes and Chemo‐Photothermal Drugs for Gastric Cancer Theragnostic
Authors
Keywordschemotherapy
extracellular vesicles
nanobodies
photothermal therapy
targeted delivery
Issue Date9-Feb-2023
PublisherWiley
Citation
Advanced Functional Materials, 2023, v. 33, n. 7 How to Cite?
Abstract

Extracellular vesicles (EVs) are widely used as natural nanoparticles to deliver various cargos for disease diagnosis and therapy. However, unmodified EVs cannot efficiently transport the cargos to desired sites due to non-specific uptake. Here, a delivery system is designed to display nanobodies against cadherin 17 (CDH17) on the surface of EVs isolated from HEK-293 cells and loaded with dye Indocyanine green (ICG) and/or anti-cancer drug dinitroazetidine derivative RRx-001, a blocker for CD47/ signal regulatory protein alpha (SIRPα) axis. CDH17 is a promising target for gastric cancer (GC) therapy. In this study, ICG loaded in the EVs engineered with CDH17 nanobodies can realize rapid tumor imaging in a CDH17-positive GC model and can produce significant anti-tumor photothermal therapeutic (PTT) effect after irradiation. Meanwhile, PTT effect can induce immunogenic cell death and macrophage polarization from M2 to M1 phenotype. The engineered EVs loaded with RRx-001 can significantly repress GC tumor growth. Finally, dual loading of ICG/RRx-001 in engineered EVs show maximal anti-tumor efficacy in both cancer cell and patient-derived GC models after only single injection. Collectively, CDH17 nanobody-functionalized EVs loaded with ICG and/or RRx-001 hold great promise to image and treat GC by combining fluorescent dye-induced PTT with chemotherapy.


Persistent Identifierhttp://hdl.handle.net/10722/340911
ISSN
2023 Impact Factor: 18.5
2023 SCImago Journal Rankings: 5.496
ISI Accession Number ID

 

DC FieldValueLanguage
dc.contributor.authorXia, Peng-
dc.contributor.authorYuan, Haitao-
dc.contributor.authorTian, Ming-
dc.contributor.authorZhong, Tianyu-
dc.contributor.authorHou, Rui-
dc.contributor.authorXu, Xiaolong-
dc.contributor.authorMa, Jingbo-
dc.contributor.authorWang, Huifang-
dc.contributor.authorLi, Zhifen-
dc.contributor.authorHuang, Defa-
dc.contributor.authorQu, Chengming-
dc.contributor.authorDai, Lingyun-
dc.contributor.authorXu, Chengchao-
dc.contributor.authorYang, Chuanbin-
dc.contributor.authorJiang, Haibo-
dc.contributor.authorHe, Yuanqiao-
dc.contributor.authorRückert, Felix-
dc.contributor.authorLi, Zhijie-
dc.contributor.authorYuan, Yufeng-
dc.contributor.authorWang, Jigang-
dc.date.accessioned2024-03-11T10:48:12Z-
dc.date.available2024-03-11T10:48:12Z-
dc.date.issued2023-02-09-
dc.identifier.citationAdvanced Functional Materials, 2023, v. 33, n. 7-
dc.identifier.issn1616-301X-
dc.identifier.urihttp://hdl.handle.net/10722/340911-
dc.description.abstract<p>Extracellular vesicles (EVs) are widely used as natural nanoparticles to deliver various cargos for disease diagnosis and therapy. However, unmodified EVs cannot efficiently transport the cargos to desired sites due to non-specific uptake. Here, a delivery system is designed to display nanobodies against cadherin 17 (CDH17) on the surface of EVs isolated from HEK-293 cells and loaded with dye Indocyanine green (ICG) and/or anti-cancer drug dinitroazetidine derivative RRx-001, a blocker for CD47/ signal regulatory protein alpha (SIRPα) axis. CDH17 is a promising target for gastric cancer (GC) therapy. In this study, ICG loaded in the EVs engineered with CDH17 nanobodies can realize rapid tumor imaging in a CDH17-positive GC model and can produce significant anti-tumor photothermal therapeutic (PTT) effect after irradiation. Meanwhile, PTT effect can induce immunogenic cell death and macrophage polarization from M2 to M1 phenotype. The engineered EVs loaded with RRx-001 can significantly repress GC tumor growth. Finally, dual loading of ICG/RRx-001 in engineered EVs show maximal anti-tumor efficacy in both cancer cell and patient-derived GC models after only single injection. Collectively, CDH17 nanobody-functionalized EVs loaded with ICG and/or RRx-001 hold great promise to image and treat GC by combining fluorescent dye-induced PTT with chemotherapy.<br></p>-
dc.languageeng-
dc.publisherWiley-
dc.relation.ispartofAdvanced Functional Materials-
dc.rightsThis work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.-
dc.subjectchemotherapy-
dc.subjectextracellular vesicles-
dc.subjectnanobodies-
dc.subjectphotothermal therapy-
dc.subjecttargeted delivery-
dc.titleSurface‐Engineered Extracellular Vesicles with CDH17 Nanobodies to Efficiently Deliver Imaging Probes and Chemo‐Photothermal Drugs for Gastric Cancer Theragnostic-
dc.typeArticle-
dc.identifier.doi10.1002/adfm.202209393-
dc.identifier.scopuseid_2-s2.0-85143542719-
dc.identifier.volume33-
dc.identifier.issue7-
dc.identifier.eissn1616-3028-
dc.identifier.isiWOS:000935011900034-
dc.identifier.issnl1616-301X-

Export via OAI-PMH Interface in XML Formats


OR


Export to Other Non-XML Formats